Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 163 clinical trials
Video Coaching of Physical Activity in Axial Spondyloarthritis (SatiSpAction)

The primary objective of the study is to demonstrate the beneficial effect of a 3 months home-based physical exercise program supervised by online videos, in addition to the usual recommendations, in comparison with usual physical activity as recommended by the WHO. The secondary objectives of the study are : to …

  • 13 Mar, 2022
Biomedicines and Bacterial Translocation in Spondyloarthritis (TEARE-BIO)

The aim of this project is to evaluate the effect of anti-TNF and anti-IL17 biotherapies on bacterial translocation in patients with NSAID-resistant axial spondyloarthritis.

  • 18 Jun, 2022
  • 1 location
Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis

The aim of this study is to determine the efficacy and safety of ADA plus MTX for the treatment in non-infectious pediatric panuveitis.

  • 09 Jan, 2022
  • 1 location
Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis

Evaluation of a new screening method for sarcopenia in rheumatoid arthritis

  • 05 Sep, 2021
  • 1 location
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial (ADVISE)

Non-infectious intermediate, posterior, and panuveitides are chronic, potentially-blinding diseases. Vision-threatening cases require long-term therapy with oral corticosteroids and immunosuppression. Based upon preliminary data, adalimumab, a fully-human, anti-TNF-α monoclonal antibody, now US FDA-approved for uveitis treatment, may be a superior corticosteroid-sparing agent than conventional immunosuppressive drugs. The ADVISE Trial is multicenter …

immunosuppressive agents
monoclonal antibodies
  • 14 Jul, 2022
  • 19 locations
Hydroxychloroquine and Indapamide in SPMS

The purpose of this clinical trial is to determine if HCQ in a dose of 400mg daily and indapamide in a dose of 2.5mg daily can help in reducing the progression of disability in people with secondary progressive multiple sclerosis. The number of participants in this study will be 35. …

  • 25 May, 2022
  • 1 location
The Clinical and Biological Effect of ESWT With Combined PRP Therapy on Rotator Cuff Lesions

Through the investigators previous study of the effect of transient increased cellular permeability after ESWT, combined ESWT and PRP may have better effect on the treatment of rotator cuff lesions. The investigators intend to conduct a prospective double blind randomized control study on the treatment effect of combined ESWT and …

  • 09 Sep, 2021
  • 1 location
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis (ATLAS)

ATLAS study is a clinical trial to evaluate the potential role of subcutaneous adrenocorticotropic hormone (ACTH) gel in the management of non-infectious scleritis. Specifically, the ATLAS Study aims to evaluate the safety, tolerability and effect of 2 different dose regimens of ACTH gel administered by subcutaneous (SC) injection in patients …

  • 04 Oct, 2022
  • 3 locations
Heated Mittens for Patients With Hand Osteoarthritis: a Randomized Controlled Trial (HOT)

The primary objective of this trial is to assess the efficacy of an intervention with heated mittens in patients with hand osteoarthritis (HOA). The joints of the hands are some of the most commonly joints affected by osteoarthritis, together with hip and knee joints. The prevalence increases with age and …

  • 28 Oct, 2022
  • 1 location
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

anti-rheumatic drugs. The long term extension period will provide additional long-term efficacy and safety information.

anti-rheumatic drugs
high sensitivity
skin lesion
plaque psoriasis
  • 14 Oct, 2022
  • 92 locations